lundi 9 janvier 2017

Onco Actu du 9 janvier 2017


4.12 Biopsies liquides

Liquid Biopsies Are About to Get a Billion Dollar Boost [MIT Technology Review]



5. Traitements

Roswell Park Research Helps Explain Why Androgen-Deprivation Therapy Doesn’t Work for Many Prostate Cancers [Roswell Park]

Experts Forecast Cancer Research and Treatment Advances in 2017 [Cancer Research Catalyst]

5.12.1 Immunothérapies - partenariats

Innate Pharma receives $15 million milestone payment from Bristol-Myers Squibb for continued exploration of lirilumab in combination with Opdivo [Innate]

5.2 Pharma

Foundation, Roche Deepen Ties as Genentech Vet Steps in for CEO Pellini [Xconomy]


5.2.1 Pharma - Partenariats

Bristol-Myers Squibb and GeneCentric Diagnostics Announce Exploratory Biomarker Research Collaboration [BMS]

5.2.3 Pharma - économie

Merrimack Hits Reset Button, Sells Cancer Drugs to Ipsen For $575M [Xconomy]

Getting to work on pipeline construction, new Ipsen CEO forges $1B deal to buy Merrimack’s struggling Onivyde [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

FDA speeds up review of Roche's Tecentriq to treat another bladder cancer [Reuters]

5.4 Traitements - Economie

Cheating Death Can Cost $200,000 as Cancer Leads Sales [Bloomberg]

6.1 Observation

Report: US cancer deaths down 25% since 1991 [CNN]

6.11 Patients

Before Breast Cancer Surgery, A Question Every Patient Should Ask Her Surgeon [Forbes]

My cancer diary: tasteless dinner on the Isle of Wight and a dash to A&E [The Guardian]

6.7 DMP, Big Data & applis

Ex-BGI CEO’s unicorn unveils health management platform, $400M investment in patient data, omics partners [FierceBiotech]

PatientsLikeMe Nabs $100M, Works to Advance Personalized Medicine [Xconomy]